Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Indications, Safety, and Efficacy Experienced at Yaoundé General Hospital
Open Journal of Nephrology · 2026 · 16 (01) · 147-160
DOI: 10.4236/ojneph.2026.161015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Journal of Nephrology, 2026. Verfasst von Mahamat Maimouna und 6 weiteren Autor:innen. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Maimouna, M., Bame, B. B., Ndobo, V., Nzana, V., Nono, A., Sylvia, V., & Menanga, P. A. (2026). Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Indications, Safety, and Efficacy Experienced at Yaoundé General Hospital. Open Journal of Nephrology, 16(01), 147-160. https://doi.org/10.4236/ojneph.2026.161015
Vancouver
Maimouna M, Bame BB, Ndobo V, Nzana V, Nono A, Sylvia V, et al. Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Indications, Safety, and Efficacy Experienced at Yaoundé General Hospital. Open Journal of Nephrology. 2026;16(01):147-160. doi:10.4236/ojneph.2026.161015
BibTeX
@article{Maimouna2026,
author = {Maimouna, Mahamat and Bame, Balkissou Bouba and Ndobo, Valerie and Nzana, Victorine and Nono, Aristide and Sylvia, Vanessa and Menanga, Paul Alain},
title = {Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors: Indications, Safety, and Efficacy Experienced at Yaoundé General Hospital},
journal = {Open Journal of Nephrology},
year = {2026},
volume = {16},
number = {01},
pages = {147--160},
doi = {10.4236/ojneph.2026.161015}
}
EUVIMED